Determining Adjuvant Therapy Through Recurrence Prediction: New Investigations

The Art and Science of Patient–Doctor Communication

Keynote Addresses Lessons from SCLC Mouse Models

CDX Models Help Bring Personalized Treatment for SCLC a Step Closer

Preconditioning Program Shortens Postsurgical Hospital Stay for People with Lung Cancer

In Brief for February 9, 2022

Multidisciplinary Tumor Boards: Six Eyes See More than Two

Unplanned Hospital Care in Patients With NSCLC

Predicting Early Weight Loss in Radiotherapy

In Brief for February 23, 2022

Determining the Most Effective Chemotherapy Regimen in Patients With Advanced KRAS-Mutated NSCLC: the NVALT22 study

Novel Targets and Therapies: KEAP1- and NFE2L2-Mutant Squamous Cell Lung Cancer